Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study

References

• Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21(6):762–778. doi:10.1093/humupd/dmv039
   PubMed Web of Science ®Google Scholar
• Osuga Y, Hayashi K, Kobayashi Y, et al. Dysmenorrhea in Japanese women. Int J Gynaecol Obstet. 2005;88(1):82–83. doi:10.1016/j.ijgo.2004.09.004
   Web of Science ®Google Scholar
• Momoeda M, Kondo M, Elliesen J, Yasuda M, Yamamoto S, Harada T. Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study. Int J Women's Health. 2017;9:295–305. doi:10.2147/IJWH.S134576
   PubMed Web of Science ®Google Scholar
• Barnard K, Frayne SM, Skinner KM, Sullivan LM. Health status among women with menstrual symptoms. J Women's Health (Larchmt). 2003;12(9):911–919. doi:10.1089/154099903770948140
   Web of Science ®Google Scholar
• Unsal A, Ayranci U, Tozun M, Arslan G, Calik E. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Ups J Med Sci. 2010;115(2):138–145. doi:10.3109/03009730903457218
   PubMed Web of Science ®Google Scholar
• Wong CL. Health-related quality of life among Chinese adolescent girls with dysmenorrhoea. Reprod Health. 2018;15(1):. doi:10.1186/s12978-018-0540-5
   Web of Science ®Google Scholar
• Ortiz MI, Rangel-Flores E, Carrillo-Alarcon LC, Veras-Godoy HA. Prevalence and impact of primary dysmenorrhea among Mexican high school students. Int J Gynaecol Obstet. 2009;107(3):240–243. doi:10.1016/j.ijgo.2009.07.031
   PubMed Web of Science ®Google Scholar
• Eryilmaz G, Ozdemir F, Pasinlioglu T. Dysmenorrhea prevalence among adolescents in eastern Turkey: its effects on school performance and relationships with family and friends. J Pediatr Adolesc Gynecol. 2010;23(5):267–272. doi:10.1016/j.jpag.2010.02.009
   PubMed Web of Science ®Google Scholar
• Wong LP, Khoo EM. Dysmenorrhea in a multiethnic population of adolescent Asian girls. Int J Gynaecol Obstet. 2010;108(2):139–142. doi:10.1016/j.ijgo.2009.09.018
   PubMed Web of Science ®Google Scholar
• Pitangui AC, Gomes MR, Lima AS, Schwingel PA, Albuquerque AP, de Araujo RC. Menstruation disturbances: prevalence, characteristics, and effects on the activities of daily living among adolescent girls from Brazil. J Pediatr Adolesc Gynecol. 2013;26(3):148–152. doi:10.1016/j.jpag.2012.12.001
   PubMed Web of Science ®Google Scholar
• Tanaka E, Momoeda M, Osuga Y, et al. Burden of menstrual symptoms in Japanese women: results from a survey-based study. J Med Econ. 2013;16(11):1255–1266. doi:10.3111/13696998.2013.830974
   PubMedGoogle Scholar
• Akiyama S, Tanaka E, Cristeau O, Onishi Y, Osuga Y. Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database. Clinicoecon Outcomes Res. 2017;9:295–306. doi:10.2147/CEOR.S127760
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Terakawa N, Taketani Y, Hoshiai H. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2011;95(6):1928–1931. doi:10.1016/j.fertnstert.2011.02.045
   PubMed Web of Science ®Google Scholar
• YAZ approved in Japan for the treatment of dysmenorrhea. The Financial website. 2011. Available from: https://www.finchannel.com/business/161-pharmacy/27581. Accessed January 2, 2019.
   Google Scholar
• Ethinylestradiol/norethisterone ultra low dose - Nobelpharma. Adis Insight website. September 30, 2013. Available from: https://adisinsight.springer.com/drugs/800033007. Accessed January 2, 2019.
   Google Scholar
• Takeda T, Wong TF, Adachi T, et al. Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2011 edition. J Obstet Gynaecol Res. 2012;38(4):615–631. doi:10.1111/j.1447-0756.2012.01858.x
   Web of Science ®Google Scholar
• Bayer. YAZ post-marketing surveillance in Japan. ClinicalTrials.gov website. June 20, 2011. [updated April 3, 2018]. Available from: https://clinicaltrials.gov/ct2/show/NCT01375998. Accessed January 2, 2019.
   Google Scholar
• Kumano S. GPSP: good post-marketing study practice. Nihon Yakurigaku Zasshi. 2012;140(2):81–84. doi:10.1254/fpj.140.81
   Google Scholar
• Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037–1044. doi:10.1016/S0895-4356(98)00095-X
   PubMed Web of Science ®Google Scholar
• Ware J, Snow K, Kosinski M, Gandek B. SF36 health survey: manual and interpretation guide. The Health Institute, New England Medical Center; 1993. Available from: https://www.researchgate.net/publication/247503121_SF36_Health_Survey_Manual_and_Interpretation_Guide. Accessed January 2, 2019.
   Google Scholar
• Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s Manual for the SF-36v2 Health Survey. Lincoln: QualityMetric Inc; 2007.
   Google Scholar
• Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol. 1998;51(11):1045–1053. doi:10.1016/S0895-4356(98)00096-1
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Suzukamo Y. Manual of SF-36v2 Japanese Version. Vol. 2004. Kyoto: iHope International Inc; 2015.
   Google Scholar
• Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. JAMA. 1989;262(7):907–913. doi:10.1001/jama.1989.03430070055030
   PubMed Web of Science ®Google Scholar
• McGovern CE, Cheung C. Yoga and quality of life in women with primary dysmenorrhea: a systematic review. J Midwifery Women's Health. 2018;63(4):470–482. doi:10.1111/jmwh.12729
   PubMed Web of Science ®Google Scholar
• Bazarganipour F, Taghavi S-A, Allan H, et al. A randomized controlled clinical trial evaluating quality of life when using a simple acupressure protocol in women with primary dysmenorrhea. Complement Ther Med. 2017;34:10–15. doi:10.1016/j.ctim.2017.07.004
   Web of Science ®Google Scholar
• Abaraogu UO, Tabansi-Ochuogu CS. As acupressure decreases pain, acupuncture may improve some aspects of quality of life for women with primary dysmenorrhea: a systematic review with meta-analysis. J Acupunct Meridian Stud. 2015;8(5):220–228. doi:10.1016/j.jams.2015.06.010
   PubMedGoogle Scholar
• Berner E, Qvigstad E, Myrvold AK, Lieng M. Pain reduction after total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy among women with dysmenorrhoea: a randomised controlled trial. BJOG. 2015;122(8):1102–1111. doi:10.1111/1471-0528.13362
   Web of Science ®Google Scholar
• Grandi G, Napolitano A, Xholli A, Tirelli A, Di Carlo C, Cagnacci A. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea. Gynecol Endocrinol. 2015;31(10):774–778. doi:10.3109/09513590.2015.1063118
   PubMed Web of Science ®Google Scholar
• Raman S, Ding K, Chow E, et al. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases. Qual Life Res. 2018;27(4):1089–1098. doi:10.1007/s11136-017-1745-8
   Web of Science ®Google Scholar
• Walters SJ, Munro JF, Brazier JE. Using the SF-36 with older adults: a cross-sectional community-based survey. Age Ageing. 2001;30(4):337–343. doi:10.1093/ageing/30.4.337
   PubMed Web of Science ®Google Scholar
• Thompson ML, Gick ML. Medical care-seeking for menstrual symptoms. J Psychosom Res. 2000;49(2):137–140. doi:10.1016/S0022-3999(00)00149-5
   Web of Science ®Google Scholar